MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Iron"

  • 2019 International Congress

    Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease

    N. Bergsland, R. Zivadinov, F. Schweser, J. Hagemeier, D. Lichter, T. Guttuso, JR. (Buffalo, NY, USA)

    Objective: To investigate spatial patterns and temporal evolution of substantia nigra (SN) iron accumulation in Parkinson’s disease (PD) using quantitative susceptibility mapping (QSM), an indirect…
  • 2019 International Congress

    In vivo increased striatal iron deposition in Parkinson’s Disease Dementia and Dementia with Lewy Body

    S. Rota, T. Yousaf, H. Wilson, G. Dervenoulas, G. Pagano, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: To evaluate iron deposition with susceptibility weighted imaging (SWI) MRI in the basal ganglia of patients affected by Parkinson’s Disease Dementia (PDD) and Dementia…
  • 2019 International Congress

    Quantification of regional iron content with Susceptibility Weighted Imaging in Huntington Disease Expansion Gene Carriers

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To assess brain iron content measured with SWI-MRI in HD gene expansion carriers (HDGECs). Background: Huntington’s Disease (HD) results in extensive neuronal cell loss,…
  • 2019 International Congress

    Safety of Iron Chelation in Patients with Brain Iron Overload

    C. Fradette, T. Klopstock, L. Neumayr, I. Karin, G. Zorzi, T. Kmieć, B. Büchner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, F. Zibordi, N. Nardocci, A. Stilman, M. Spino, E. Vichinsky, F. Tricta (Toronto, ON, Canada)

    Objective: To assess the safety of iron chelation in the treatment of regional brain iron overload. Background: Excess brain iron is evident in neurodegenerative diseases…
  • 2019 International Congress

    Iron Supplementation for the Treatment of Restless Legs Syndrome – A Systematic Review and Meta-Analysis

    M. Kestenbaum, N. Lev (Kfar Saba, Israel)

    Objective: To gather the evidence for the efficacy and safety of iron supplementation for restless legs syndrome (RLS). Background: Iron supplementation is used for the…
  • 2019 International Congress

    Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease

    S. Franthal, L. Pirpamer, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, F. Fazekas, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: The aim of our study was to determine the diagnostic value of nigral iron depositions in PD, measured by iron specific MRI-techniques. Background: Nigral…
  • 2018 International Congress

    PBT434 prevents the accumulation of glial cell inclusions and insoluble alpha-synuclein in a mouse model of Multiple System Atrophy

    D. Finkelstein, P. Adlard, N. Stefanova, D. Stamler (Parkville, Vic, Australia)

    Objective: To evaluate PBT434 in a transgenic mouse model of multiple system atrophy (MSA) Background: PBT434 is a novel quinazolinone inhibitor of iron-mediated protein accumulation…
  • 2018 International Congress

    Seasonal Fluctuation in a Chinese cohort of patients with idiopathic Restless Legs Syndrome

    XY. Zhu, LY. Ni, Y. Liu, XJ. Zhang, WH. Yang, YC. Wu (Shanghai, China)

    Objective: To evaluate incidence and characteristics of seasonal fluctuation in a Chinese cohort of patients with idiopathic RLS in order to differentiate possible subtypes and…
  • 2018 International Congress

    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson’s disease

    S. Qian, Y. Sheng, Z. Zhong (Nanjing, China)

    Objective: To examine plasma iron metabolism related indicators in patients with Parkinson’s disease (PD) and investigate the mechanism underlying the tremor-dominant phenotype of PD. Background:…
  • 2018 International Congress

    Longitudinal development of nigral iron load in Parkinson’s Disease

    S. Franthal, L. Pirpamer, C. Rodler, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: We for the first time investigated longitudinal changes of nigral iron load in Parkinson’s disease (PD) measured by Quantitative Susceptibility Mapping (QSM), a highly…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley